← Open Payments lookup

KENDALL CHILD: Open Payments

NPI 1255300851 · BOZEMAN, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$238 in 11 payments from 8 companies in 2025. Trend: 2023 $684 · 2024 $212 · 2025 $238

Food & beverage: $238
CompanyPaymentsAmount
Merck Sharp & Dohme LLC3$58
AstraZeneca Pharmaceuticals LP2$47
RECORDATI_RARE_DISEASES_INC.1$30
ARRAY BIOPHARMA INC1$26
ABBVIE INC.1$23
Novocure Inc.1$22
ADC THERAPEUTICS AMERICA, INC.1$19
Celgene Corporation1$14

Products named: KEYTRUDA, SYLVANT, IMFINZI, BRAFTOVI, IMBRUVICA, ZYNLONTA, KEYTRUDA QLEX, REBLOZYL.

Industry payments across MT — which companies pay providers there.